Cart
sales@molnova.com
Acitazanolast
CAS No. 114607-46-4
Acitazanolast( MTCC | WP-871 )
Catalog No. M21633 CAS No. 114607-46-4
Acitazanolast is an anti-allergic drug candidate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 47 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcitazanolast
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcitazanolast is an anti-allergic drug candidate.
-
DescriptionAcitazanolast is an anti-allergic drug candidate.
-
In Vitro——
-
In Vivo——
-
SynonymsMTCC | WP-871
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
IndicationAllergic conjunctivitis
Chemical Information
-
CAS Number114607-46-4
-
Formula Weight233.19
-
Molecular FormulaC9H7N5O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 35.71 mg/mL (153.14 mM)
-
SMILESOC(=O)C(=O)Nc1cccc(c1)-c1nnn[nH]1
-
Chemical NameOxo-((3-(1H-tetrazol-5-yl)phenyl)amino)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kamei C Mio M Yoshida T Saito Y Toyoda Y Tsuriya Y. Effect of an active metabolite of the antiallergic agent tazanolast on histamine release from rat mast cells. Arzneimittelforschung. 1997 Apr;47(4):390-4.
molnova catalog
related products
-
[D-Phe7]-Somatostati...
(D-Phe7)-Somatostatin-14 is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
-
Zolbetuximab
Zolbetuximab(IMAB362) is a monoclonal antibody that specifically targets Claudin-18.2.Zolbetuximab has potential antitumor activity, mediating killing of Claudin-18.2-positive cells through an immune effector mechanism.
-
BTM - P1
BTM - P1
